Bixiye
QP43-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: May 14, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 251 - 260 ee natiijooyinka 3165
Bixiye
QP42-25 MHCP Pharmacy Benefit Exclusion for Encelto™ and Ryoncil®
Taariikhda uu dhaqangalayo Barnaamijka: May 14, 2025
Bixiye
QP41-25 Commercial Pharmacy Benefit Exclusion for Encelto™, Epysqli® and Ryoncil®
Taariikhda uu dhaqangalayo Barnaamijka: May 14, 2025
Bixiye
QP40-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: May 14, 2025
Bixiye
QP39-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: May 14, 2025
Bixiye
QP80R2-21 BlueRide announces No-Load Program for Non-Emergency Medical Transportation (NEMT) in Greater Minnesota
Taariikhda uu dhaqangalayo Barnaamijka: May 14, 2025
Bixiye
BCBS and Blue Plus Medicare Advantage (PPO) Prior Authorization and Notification Requirements
Bixiye
P31-25 Change to Provider Policy and Procedure Manual for Aware, Blue Plus Referral and Durable Medical Equipment Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2025
Bixiye
Metformin ER - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Rezurock® (belumosudil) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025